Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01741311
What this trial is testing

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

Who this might be right for
Risk BehaviorMedication AdherenceHIV
University of Connecticut 106
Not applicableStudy completedNCT03086200
What this trial is testing

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

Who this might be right for
Patient AdherenceHIV Seronegativity
University of California, San Diego 263
Not applicableStudy completedNCT03175159
What this trial is testing

Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse

Who this might be right for
Stimulant AbuseHIV PreventionSubstance Abuse
University of California, Los Angeles 205
Not applicableStudy completedNCT05338996
What this trial is testing

Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of Color

Who this might be right for
HIV PreventionPrEP Adherence
Florida International University 72
Post-approval studies (Phase 4)Study completedNCT02316444
What this trial is testing

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

Who this might be right for
HIV/AIDS and Infections
Fred Hutchinson Cancer Center 132
Not applicableStudy completedNCT01392430
What this trial is testing

Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients

Who this might be right for
HIV Infection
Chiang Mai University 74
Large-scale testing (Phase 3)Study completedNCT05140954
What this trial is testing

The Women TAF-FTC Benchmark Study

Who this might be right for
HIV Infections
University of Washington 54
Not applicableStudy completedNCT03511131
What this trial is testing

A Pragmatic Trial of An Adaptive eHealth HIV Prevention Program for Diverse Adolescent MSM

Who this might be right for
HivAdolescent BehaviorSex, Safe
Northwestern University 1,306
Not applicableStudy completedNCT00002438
What this trial is testing

Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients

Who this might be right for
HIV InfectionsHistoplasmosis
Janssen, LP
Not applicableStudy completedNCT04531943
What this trial is testing

Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women

Who this might be right for
HIV Prevention
Emory University 285
Not applicableStudy completedNCT01804023
What this trial is testing

Biomarkers of Protocol Compliance and Product Adherence

Who this might be right for
HIV Prevention
CONRAD 40
Not applicableStudy completedNCT00142935
What this trial is testing

Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1

Who this might be right for
HIV PreventionOpioid-Related Disorders
The Miriam Hospital 87
Not applicableStudy completedNCT05286879
What this trial is testing

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

Who this might be right for
Opioid Use DisorderInfectious DiseaseRisk Reduction Behavior+3 more
Yale University 601
Post-approval studies (Phase 4)Study completedNCT03980223
What this trial is testing

Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

Who this might be right for
GonorrheaChlamydiaSyphilis
University of California, San Francisco 641
Not applicableActive Not RecruitingNCT04090723
What this trial is testing

Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum

Who this might be right for
HIVAlcohol; Harmful UseMental Health Disorder
Johns Hopkins University 12
Large-scale testing (Phase 3)Study completedNCT04597424
What this trial is testing

Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Unsafe SexRisk-Taking
ANRS, Emerging Infectious Diseases 556
Not applicableStudy completedNCT02946762
What this trial is testing

TasP in Correctional Facilities

Who this might be right for
HIVTuberculosis
University of North Carolina, Chapel Hill 419
Testing effectiveness (Phase 2)Study completedNCT01412801
What this trial is testing

Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings

Who this might be right for
Streptococcal InfectionsGram-Positive Bacterial InfectionsBacterial Infections
Novartis Vaccines 270
Post-approval studies (Phase 4)Study completedNCT05072093
What this trial is testing

Parrying the Pitfalls of PrEP: Project PEACH

Who this might be right for
HIVSTI
Emory University 240
Not applicableStudy completedNCT05452616
What this trial is testing

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
University Hospital, Basel, Switzerland 610
Next Page